The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 01, 2015
Filed:
May. 02, 2014
Applicant:
Astrazeneca Ab, Sodertalje, SE;
Inventors:
Dilbir S. Bindra, New Brunswick, NJ (US);
Mandar V. Dali, Bridgewater, NJ (US);
Prakash V. Parab, New Brunswick, NJ (US);
Jatin M. Patel, New Brunswick, NJ (US);
Li Tao, New Brunswick, NJ (US);
Ravindra W. Tejwani, Monmouth Junction, NJ (US);
Nipa Vatsaraj, New Brunswick, NJ (US);
Yongmei Wu, New Brunswick, NJ (US);
Assignee:
AstraZeneca AB, Sodertalje, SE;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/7034 (2006.01); A61K 9/16 (2006.01); A61K 31/403 (2006.01); A61K 9/20 (2006.01); A61K 45/06 (2006.01); A61K 31/155 (2006.01); A61K 31/70 (2006.01); A61K 9/00 (2006.01); A61K 9/08 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7034 (2013.01); A61K 9/0095 (2013.01); A61K 9/08 (2013.01); A61K 9/16 (2013.01); A61K 9/1652 (2013.01); A61K 9/20 (2013.01); A61K 9/2054 (2013.01); A61K 31/155 (2013.01); A61K 31/403 (2013.01); A61K 31/70 (2013.01); A61K 45/06 (2013.01);
Abstract
Pharmaceutical formulations are provided which are in the form of capsules or tablets for oral use and which include a medicament dapagliflozin or its propylene glycol hydrate and a pharmaceutical acceptable carrier therefor, which formulation is designed for immediate release.